Latest Avapro Stories

PARIS, Oct. 25, 2012 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q3 2012 Change on a reported Change at 9-month 2012 Change on a reported basis basis Change at constant constant exchange rates(1)...

PARSIPPANY, N.J., Oct. 12, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc. has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Irbesartan Tablets USP, 75 mg, 150 mg and 300 mg, the generic equivalent to Sanofi's Avapro(®). Watson intends to begin shipping the product immediately. Avapro(®) is indicated for the treatment of hypertension...

PARIS, July 26, 2012 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q2 2012 Change on a Change at H1 2012 Change on a Change at reported constant reported constant basis exchange rates(1) basis exchange rates ----- ---------------- ----- -------------- Net sales...

PARIS, April 27, 2012 /PRNewswire/ -- (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Q1 2012 Change on a Change at constant reported basis exchange rates -------------- -------------- Net sales euro 8,511m +9.4% +7.0% Business net income(1) euro 2,442m +12.5% +8.4%...

PARIS, Feb. 8, 2012 /PRNewswire/ -- (Logo : http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Change at Change at Q4 2011 Change on a constant 2011 Change on a constant ------- ----------- --------- ---- ----------- --------- reported...